D68.52
Prothrombin gene mutation
Clinical Classification Guidelines
Medical Intelligence & Overview
Prothrombin gene mutation is a hereditary condition that increases the risk of developing abnormal blood clots. Also known as factor II mutation, this genetic variation influences blood clotting and may lead to a higher chance of blood clot-related health problems. Understanding this condition can help individuals manage the associated risks and seek appropriate medical care.
Causes & Symptoms
Clinical Causes: Inherited genetic mutation in the prothrombin gene (F2 gene). Autosomal dominant inheritance pattern, meaning only one copy of the mutated gene can increase risk. Family history of blood clots or thrombotic disorders.
Key Symptoms: Often no symptoms are present until a blood clot forms. Deep vein thrombosis (DVT) symptoms such as swelling, pain, and redness in the affected limb. Pulmonary embolism symptoms including sudden shortness of breath, chest pain, and rapid heartbeat. Recurrent pregnancy loss or complications during pregnancy in some women.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically made through a blood test called genetic testing, which detects mutations in the prothrombin gene. This test is often considered when there is a history of unexplained blood clots or a family history of thrombotic disorders. Additional blood tests may include coagulation profiles and other genetic assessments to evaluate clotting risk.
Treatment Protocols: Anticoagulant medications such as warfarin or direct oral anticoagulants (DOACs). Lifestyle modifications including maintaining a healthy weight, regular exercise, and avoiding smoking. Monitoring during high-risk situations like surgery or prolonged immobilization. Pregnancy management plans in women with the mutation to reduce pregnancy-related complications.
Clinical Advice & FAQs
Billing Guidance
Is D68.52 a billable ICD-10 code?
Yes, D68.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D68.52?
Clinical documentation must specify the nature of Prothrombin gene mutation and any associated comorbidities for accurate reporting.
Cite this Clinical Reference